| CAS No. | CATO-C4X-324051 |
| Molecular Formula | - |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
The occurrence of Tirzepatide Impurity 51 is closely related to a structurally diverse molecular composition in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
As a process- or degradation-related impurity, Tirzepatide Impurity 51 (CAS CATO-C4X-324051, N/A) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Tirzepatide Impurity 51 is supplied as a fully characterized reference material; its structural identity, assigned purity, and stability data are documented in the batch-specific Certificate of Analysis (COA).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Tirzepatide Impurity 51 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Purity | ≥90% |
| Storage | Store at 2-8°C |
| Solubility (reference) | Freely soluble in water |
| Stability | Stable under recommended storage conditions |